Quantitation of basal endogenous glucose production in Type II diabetes: Importance of the volume of distribution

Diabetologia

Volumn 45, Issue 8, 2002, Pages 1053-1084

  Radziuk, J ^a   Pye, S ^a  

^a UNIVERSITY OF OTTAWA   (Canada)

Author keywords

Circadian rhythms; Glucose production; Mathematical models; Metabolic clearance rates; Tracer kinetics; Type II diabetes

Indexed keywords

GLUCOSE; GLUCOSE DERIVATIVE; TRACER;

CIRCADIAN RHYTHM; COMPARTMENT MODEL; DIET RESTRICTION; DISTRIBUTION VOLUME; GLUCONEOGENESIS; GLUCOSE METABOLISM; HUMAN; MATHEMATICAL MODEL; MEAL; METABOLIC CLEARANCE RATE; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REVIEW; STEADY STATE;

ANIMALS; DIABETES MELLITUS, TYPE 2; GLUCOSE; HOMEOSTASIS; HUMANS; MODELS, BIOLOGICAL; TISSUE DISTRIBUTION;

EID: 0036366985     PISSN: 0012186X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00125-002-0841-6     Document Type: Review

References (165)

1. Pathogenesis of Type II (non-insulin dependent) diabetes mellitus: A balanced overview
2. Postprandial hyperglycemia in patients with non-insulin-dependent diabetes mellitus. Role of hepatic and extra-hepatic tissues
3. Role of hyperglucagonemia in maintenance of increased rates of hepatic glucose output in type II diabetes
4. Effects of fasting on plasma glucose and prolonged tracer measurement of hepatic glucose output in NIDDM
5. The triumvirate: Beta cell, muscle, liver. A collusion responsible for NIDDM
6. Predominant role of gluconeogenesis in increased hepatic glucose production in NIDDM
7. Carbohydrate metabolism in non-insulin-dependent diabetes mellitus
8. Role of hepatic glucose production and glucose uptake in the pathogenesis of fasting hyperglycemia in type 2 diabetes: Normalization of glucose kinetics by short-term fasting
9. Role of reduced suppression of glucose production and diminished early insulin release in impaired glucose tolerance
10. The disposal of an oral glucose load in patients with non-insulin-dependent diabetes
11. Insulin sensitivity of suppression of endogenous glucose production is the single most important determinant of glucose tolerance
12. Periperal tissue glucose uptake is not reduced after an oral glucose load in southern Italian subjects at risk of developing non-insulin-dependent diabetes mellitus
13. Type 2 diabetes impairs splanchnic uptake of glucose but does not alter intestinal glucose absorption during enteral glucose feeding. Additional evidence for a defect in hepatic glucokinase activity
14. Mechanism of improvement in glucose metabolism after chronic glyburide therapy
15. 3H-glucose infusion
16. Insulin resistance but normal basal rates of glucose production in patients with newly diagnosed mild diabetes mellitus
17. Pathogenesis of Type II (non-insulin dependent) diabetes mellitus: The role of skeletal muscle glucose uptake and hepatic glucose production in the development of hyperglycemia. A critical comment
18. Relationship between hepatic glucose production and fasting plasma glucose concentration in patients with NIDDM
19. Measurement of post-absorptive glucose kinetics in non-insulin-dependent diabetic patients: Methodological aspects
20. Effect of time on measurement of hepatic glucose production
21. Relationship between plasma glucose and insulin concentration, glucose production, and glucose disposal in normal subjects and patients with non-insulin-dependent diabetes
22. 3H-glucose infusion
23. Production and metabolic clearance of glucose under basal conditions in Type II diabetes
24. Measurement of hepatic glucose output, Krebs cycle, and gluconeogenic fluxes by NMR analysis of a single plasma glucose sample
25. Hormone-fuel interrelationships during fasting
26. Renal substrate exchange in human diabetes mellitus
27. Insulin regulation of renal glucose metabolism in conscious dogs
28. Uptake and release of glucose by the human kidney: Postabsorptive rates and response to epinephrine
29. Abnormal renal and hepatic glucose metabolism in type 2 diabetes mellitus
30. Role of human liver, kidney and skeletal muscle in postprandial glucose homeostasis
31. Absorption products of D-fructose in man
32. Rat small intestine is an insulin-sensitive gluconeogenic organ
33. Contributions by kidney and liver to glucose production in the post-absorptive state and after 60 h of fasting
34. Assessment of postabsorptive renal glucose metabolism in humans with multiple glucose tracers
35. Physiological effects of metabolic fuels on carbohydrate metabolism. I. Acute effects of elevation of plasma free fatty acids on hepatic glucose output, peripheral glucose utilization, serum insulin and plasma glucagon levels
36. Hepatic blood flow measurement. A comparison of the indocyanine green and electromagnetic techniques in normal and abnormal flow states in the dog
37. Tracer methods and the metabolic disposal of a carbohydrate load in man
38. Functional hepatocellular heterogeneity
39. Influence of physiologic hyperglucagonemia on basal and insulin-inhibited splanchnic glucose output in normal man
40. Oral glucose tolerance test: Effect of different glucose loads on splanchnic carbohydrate and substrate metabolism in healthy men
41. Splanchnic and peripheral glucose and amino acid metabolism in diabetes mellitus
42. Insulin production rate, hepatic insulin retention and splanchnic carbohydrate metabolism after oral glucose ingestion in hyperinsulinaemic Type II (non-insulin-dependent) diabetes mellitus
43. Theory of the use of arteriovenous concentration differences for measuring metabolism in steady and nonsteady states
44. A compartmental model to quantitate in vivo glucose transport in the human forearm
45. A model to measure insulin effects on glucose transport and phosphorylation in muscle: A three-tracer study
46. Glucose-2-t as a tracer for glucose metabolism
47. Testing of assumptions made in estimating the extent of futile cycling
48. 14C]glucose
49. On the mechanism of action of phosphoglucose isomerase and phosphomannose isomerase
50. Measuring glucose and fructose-6-phosphate cycling in liver in vivo
51. 3H]glucose. Differences in the apparent pattern of insulin resistance depending on isotope used
52. Quantitative contributions of gluconeogenesis to glucose production during fasting in type 2 diabetes mellitus
53. Substrate cycling between gluconeogenesis and glycolysis in euthyroid, hypothyroid and hyperthyroid man
54. Glucose and fructose-6-phosphate cycle in humans
55. 14C
56. Quantitative estimation of the Cori cycle in the human
57. 12C atoms in the pathway of gluconeogenesis in vivo
58. Gluconeogenesis from labeled carbon: Estimating isotope dilution
59. Determination of pathways of glycogen synthesis and the dilution of the three carbon pool with [U-13C]glucose
60. Analysis of mass isotopomer data
61. Influences of glucose loading and of injected insulin on hepatic glucose output
62. Glucoregulatory responses in normal and diabetic dogs recorded by a new tracer method
63. Non-invasive tracing of liver intermediary metabolism in normal subjects and in moderately hyperglycemic NIDDM subjects. Evidence against increased gluconeogenesis and hepatic fatty acid oxidation in NIDDM
64. Influence of obesity and type 2 diabetes on gluconeogenesis and glucose output in humans. A quantitative study
65. 14 glucose kinetic studies in normal, diabetic, and acromegalic subjects
66. Blood glucose replacement rates in normal and diabetic humans
67. Quantitative estimation of the Cori cycle in the human
68. Glucose dynamics in normal subjects and diabetic patients before and after a glucose load
69. Study of the relationship between plasma insulin concentration and efficiency of glucose uptake in normal and mildly diabetic subjects
70. Glucose turnover and disposal in maturity-onset diabetes
71. Effect of insulin on glucose production and utilization in diabetes
72. Differential effects of insulin therapy on hepatic and peripheral insulin sensitivity in Type II (non-insulin-dependent) diabetes
73. Assessment of insulin action in NIDDM in the presence of dynamic changes in insulin and glucose concentration
74. Increased lipolysis and its consequences on gluconeogenesis in non-insulin-dependent diabetes mellitus
75. Increased rate of gluconeogenesis in type II diabetes mellitus. A 13C nuclear magnetic resonance study
76. The impact of metformin therapy on hepatic glucose production and skeletal muscle glycogen synthase activity in overweight type II diabetic patients
77. Glucose-6-phosphatase flux in vitro is increased in type 2 diabetes
78. Mechanism by which metformin reduces glucose production in type 2 diabetes
79. Assessment of hepatic insulin action in obese type 2 diabetic patients
80. Fasting hyperglycemia in non-insulin-dependent diabetes mellitus: Contributions of excessive hepatic glucose production and impaired tissue glucose uptake
81. Glucose fluxes and oxidation after an oral glucose load in patients with non-insulin-dependent diabetes mellitus of variable severity
82. Evidence for increased systemic glucose production and gluconeogenesis in an early stage of NIDDM
83. Gluconeogenesis in moderately and severely hyperglycemic patients with type 2 diabetes mellitus
84. Effect of physiological hyperinsulinemia on gluconeogenesis in non-diabetic subjects and in type 2 diabetic patients
85. Net splanchnic glucose production in normal man and in various disease states
86. Hepatic glucose output and hepatic insulin sensitivity in diabetes mellitus
87. Splanchnic and leg exchange of glucose, amino acids, and free fatty acids during exercise in diabetes mellitus
88. Effects of insulin on peripheral and splanchnic glucose metabolism in noninsulin-dependent (type II) diabetes
89. Optimal segments: A method for smoothing tracer data to calculate metabolic fluxes
90. On the hormonal regulation of carbohydrate metabolism: Studies with C14 glucose
91. Insulin sensitivity and its measurement: Structural commonalities among the methods
92. Effect of insulin on the distribution and disposition of glucose in man
93. Experimental validation of glucose turnover in non-steady state
94. Is the "pool fraction" paradigm a valid model for the assessment of in vivo turnover in non-steady state?
95. Non-steady state: Error analysis of Steele's model and developments for glucose kinetics
96. 14C-glucose in the dog
97. Using what is accessible to measure that which is not: Necessity of a model of system
98. Modelling and the use of tracers in the analysis and exogenous control of glucose homeostasis
99. Initial splanchnic extraction of ingested glucose in normal man
100. Hepatic glycogen formation by direct uptake of glucose following oral glucose loading in man
101. Abnormal meal carbohydrate disposition in insulin-dependent diabetes
102. Glucose metabolism during starved to fed transition in obese patients with NIDDM
103. Simultaneous time-varying systemic appearance of oral and hepatic glucose in adults monitored with stable isotopes
104. Plasma glucose metabolism during exercise in humans
105. Glucose production during exercise in humans: A-hv balance and isotopic-tracer measurements compared
106. Hyperglycemia inhibits glucose production in man independent of changes in glucoregulatory hormones
107. Hyperglycemia per se (insulin and glucagon withdrawn) can inhibit glucose production in man
108. Dose-response characteristics for effects of insulin on production and utilization of glucose in man
109. Mechanism by which hyperglycemia inhibits hepatic glucose production in conscious rats. Implications for the pathophysiology of fasting hyperglycemia in diabetes
110. Mechanisms by which glucose and insulin inhibit net hepatic glycogenolysis in humans
111. Role of the liver in pathophysiology of NIDDM
112. The metabolic clearance of glucose: Measurement and meaning
113. Is muscle the major site of insulin resistance in Type II (non-insulin-dependent) diabetes mellitus?
114. Assessment of insulin action and glucose effectiveness in diabetic and nondiabetic humans
115. The effects of non-insulin-dependent diabetes mellitus on the kinetics of onset of insulin action in hepatic and extra-hepatic tissues
116. Contribution of abnormal muscle and liver metabolism to post-prandial hyperglycemia in noninsulin-dependent diabetes mellitus
117. The role of splanchnic glucose output in determining glycemic responses after mixed meal in Type 2 diabetic patients and normal subjects
118. Regulation of endogenous glucose production by glucose per se is impaired in type 2 diabetes mellitus
119. Hyperglycemia contributes to insulin resistance in hepatic and adipose tissue but not skeletal muscle of ZDF rats
120. Glucosamine-induced inhibition of liver glucokinase impairs the ability of hyperglycemia to suppress endogenous glucose production
121. The direct and indirect effects of insulin on hepatic glucose production in vivo
122. Hepatic and extrahepatic insulin action in humans: Measurement in the absence of non-steady-state error
123. Effects of insulin on glucose turnover rates in vivo: Isotope dilution versus constant specific activity technique
124. Hypersecretion of gastric inhibitory polypeptide in diabetes mellitus
125. Identification and actions of gastric inhibitory polypeptide
126. What if Minkowski had been ageusic? An alternative angle on diabetes
127. The fourth musketeer: From Alexandre Dumas to Claude Bernard
128. The glucose fatty-acid cycle: Its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus
129. Role of insulin resistance in the pathophysiology of non-insulin dependent diabetes mellitus
130. Effect of fatty acids on glucose production and utilization in man
131. Effects of fat on insulin-stimulated carbohydrate metabolism in normal men
132. Effects of fat on glucose uptake and utilization in patients with non-insulin-dependent diabetes
133. Diurnal variation in the levels of glucose and related substances in healthy diabetic subjects during starvation
134. Diurnal variation in glucose tolerance
135. Evidence for a circadian rhythm of insulin sensitivity in patients with NIDDM caused by cyclic changes in hepatic glucose production
136. The "dawn phenomenon" - A common occurrence in both non-insulin-dependent and insulin-dependent diabetes mellitus
137. Metabolic effects of short-termj elevations of plasma cortisol are more pronounced in the evening than in the morning
138. Early morning hyperglycemia "dawn phenomenon" in non-insulin dependent diabetes mellitus (NIDDM): Effects of cortisol suppression by metyrapone
139. Contribution of cortisol to glucose counterregulation in humans
140. Blood glucose response to stress hormone exposure in healthy man and insulin dependent diabetic patients: Prediction by computer modeling
141. Effects of morning cortisol elevation on insulin secretion and glucose regulation in humans
142. Sleep-associated fall in glucose disposal and hepatic glucose output in normal humans: Putative signaling mechanism linking peripheral and hepatic events
143. Roles of circadian rhythmicity and sleep in human glucose regulation
144. Suppression of the nocturnal rise in growth hormone reduces subsequent lipolysis in subcutaneous adipose tissue
145. A suprachiasmatic nucleus generated rhythm in basal glucose concentrations
146. Glucose toxicity
147. Glucosamine induces insulin resistance in vivo by affecting GLUT 4 translocation in skeletal muscle. Implications for glucose toxicity
148. Effects of prolonged glucose infusion on insulin secretion, clearance and action in normal subjects
149. Perspective: Hexosamines and nutrient sensing
150. Labelled glucose infusate technique in clamp studies. Is precise matching of glucose specific activity important?
151. The passage of glucose through the cell membrane of the capillary endothelium
152. Plasma and interstitial glucose dynamics after intravenous glucose injection
153. Impaired glucose transport as a cause of decreased insulin-stimulated muscle glycogen synthesis in type 2 diabetes
154. Roles of glucose transport and glucose phosphorylation in muscle insulin resistance of NIDDM
155. Validity of a tracer injection method for studying glucose turnover in normal dogs
156. Rates of production, utilization, accumulation and apparent distribution space of glucose. Effects of insulin in dogs using a validated tracer method
157. Concepts, properties, measurement, and computation of clearance rates of hormones and other substances in biological systems
158. Mathematical basis for the measurement of the rates of glucose appearance and synthesis in vivo
159. The differential equations for specific activities of a distributed tracer system
160. Measuring rates of appearance in systems which are not in steady state
161. An integral equation approach to measuring turnover in non-steady compartmental and distributed systems
162. The mathematical basis of the interpretation of tracer experiments in closed steady-state systems
163. Tracer dynamics: A tentative approach and definition of fundamental concepts